Mankind Pharma Ltd. logo

Mankind Pharma Ltd. (MANKIND)

Market Closed
7 Aug, 22:00
MSE MSE
2,439. 00
+8.1
+0.3332%
- Market Cap
80.8 P/E Ratio
2% Div Yield
9,284 Volume
45.62 Eps
2,430.9
Previous Close
Add Transaction
Day Range
2,411.55 2,451.85
Year Range
1,909.9 2,670
Want to track MANKIND and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

MANKIND closed Friday higher at ₹2,439, an increase of 0.3332% from Thursday's close, completing a monthly decrease of -4.3942% or -₹112.1. Over the past 12 months, MANKIND stock gained 10.1875%.
MANKIND pays dividends to its shareholders, with the most recent payment made on Aug 30, 2025. The next estimated payment will be in 11 months ago on Aug 30, 2025 for a total of ₹1.
The last earnings report, released on Jun 02, 2026, missed the consensus estimates by -11.55%. On average, the company has fell short of earnings expectations by -3.8467%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XNSE (INR).

MANKIND Chart

Mankind Pharma Ltd. (MANKIND) FAQ

What is the stock price today?

The current price is ₹2,439.00.

On which exchange is it traded?

Mankind Pharma Ltd. is listed on MSE.

What is its stock symbol?

The ticker symbol is MANKIND.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 2%.

What is its market cap?

As of today, no market cap data is available.

Has Mankind Pharma Ltd. ever had a stock split?

No, there has never been a stock split.

Mankind Pharma Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Javier Perez Freije CEO
MSE Exchange
INE634S01028 ISIN
Switzerland Country
2,291 Employees
8 Aug 2025 Last Dividend
- Last Split
- IPO Date

Overview

Mankind Pharma Limited is a prestigious entity in the pharmaceutical sector, with a focus on developing, manufacturing, and marketing an extensive range of pharmaceutical formulations and consumer healthcare products. With its roots firmly established in 1986 in New Delhi, India, the company has expanded its reach both nationally and internationally. Mankind Pharma's commitment to health extends beyond borders, covering a wide array of therapeutic areas that include acute and chronic conditions. It prides itself on being a leading provider of a variety of healthcare solutions, catering to diverse medical needs and ensuring wellness is accessible to all.

Products and Services

  • Pharmaceuticals: Mankind Pharma is renowned for its extensive portfolio of pharmaceutical products catering to various therapeutic domains such as anti-infective, cardiovascular, gastrointestinal, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, and respiratory diseases. The company's dedication to quality and innovation ensures that each product meets the highest standards of safety and efficacy, addressing the complex needs of patients suffering from acute and chronic conditions.
  • Consumer Healthcare Products: Beyond conventional pharmaceuticals, Mankind Pharma offers a broad spectrum of consumer healthcare products. This range includes condoms under the brand Manforce, designed for safer sexual health; Prega News for pregnancy detection; emergency contraceptives like Unwanted-72 to provide options for women; Gas-O-Fas for relief from digestive issues; Health OK, a supplement for overall health; and AcneStar for skincare. Each product is developed with the consumer's health and well-being in mind, offering quality solutions for everyday health care needs.
  • Other Ventures: Mankind Pharma's business interests also extend into trading and exporting of pharmaceutical and healthcare products, underscoring its global vision. The company is involved in the manufacture of packing materials and ayurvedic products, highlighting its commitment to embracing traditional and alternative healthcare solutions. Furthermore, Mankind Pharma ventures into real estate, leasing, and hospitality, diversifying its portfolio while maintaining its core focus on health and wellness. The provision of IT services signifies the company's adaptation to digital advances, ensuring efficiency and modernization in its operations.

Contact Information

Address: Ebnaterstrasse 79
Phone: +44 20 7355 9810